The role of CD4+CD28(null) T-lymphocytes and statins in rheumatoid arthritis and unstable atherosclerotic plaque.
Rammos
Georgios
G
Department of Clinical Therapeutics, Athens University, School of Medicine, Alexandra Hospital, Athens, Greece.
Kondomerkos
Dimitrios
D
D000789:Angina, Unstable / Q000188:drug therapy / Q000276:immunology; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000276:immunology; D018106:CD28 Antigens / Q000276:immunology*; D015496:CD4-Positive T-Lymphocytes / Q000187:drug effects* / Q000276:immunology; D002986:Clinical Trials as Topic; D003324:Coronary Artery Disease / Q000188:drug therapy* / Q000276:immunology; D016207:Cytokines / Q000276:immunology; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000276:immunology* / Q000627:therapeutic use; D007108:Immune Tolerance; D016896:Treatment Outcome
D018106:CD28 Antigens; D016207:Cytokines; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors